| abstract |
A process for preparing a crystalline form of a rapamycin analog, which process comprises: ncombining the rapamycin analog with at least one organic medium to form a mixture that is saturated with the rapamycin analog; nincubating the saturated mixture until the rapamycin analog crystallizes; and recovering the crystalline rapamycin analog from the organic medium. |